FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). |
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
SEATTLE GENETICS INC /WA [ SGEN ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
3. Date of Earliest Transaction
(Month/Day/Year) 07/09/2007 | ||||||||||||||||||||||||||
4. If Amendment, Date of Original Filed
(Month/Day/Year) 07/11/2007 |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Class A Common Stock | 07/09/2007 | C | 2,263,980 | A | (7) | 2,263,980 | D | |||
Class A Common Stock | 07/09/2007 | C | 559,850 | A | (7) | 559,850 | I | See Footnote(1) | ||
Class A Common Stock | 07/09/2007 | C | 284,160 | A | (7) | 284,160 | I | See Footnote(2) | ||
Class A Common Stock | 07/09/2007 | C | 76,320 | A | (7) | 76,320(11) | I | See Footnote(3) | ||
Class A Common Stock | 07/09/2007 | C | 31,660 | A | (7) | 31,660 | I | See Footnote(4) | ||
Class A Common Stock | 07/09/2007 | C | 210,390 | A | (7) | 210,390 | I | See Footnote(5) | ||
Class A Common Stock | 07/09/2007 | C | 1,058,640 | A | (7) | 1,058,640 | I | See Footnote(6) |
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Warrants | $6.25 | 07/08/2003 | 12/31/2011 | Common Stock | 469,594 | 469,594 | D | ||||||||
Warrants | $6.25 | 07/08/2003 | 12/31/2011 | Common Stock | 101,421 | 101,421 | I | See Footnote(1) | |||||||
Warrants | $6.25 | 07/08/2003 | 12/31/2011 | Common Stock | 13,826 | 13,826 | I | See Footnote(2) | |||||||
Warrants | $6.25 | 07/08/2003 | 12/31/2011 | Common Stock | 51,478 | 51,478 | I | See Footnote(3) | |||||||
Warrants | $6.25 | 07/08/2003 | 12/31/2011 | Common Stock | 5,736 | 5,736 | I | See Footnote(4) | |||||||
Warrants | $6.25 | 07/08/2003 | 12/31/2011 | Common Stock | 38,114 | 38,114 | I | See Footnote(5) | |||||||
Warrants | $6.25 | 07/08/2003 | 12/31/2011 | Common Stock | 132,331 | 132,331 | I | See Footnote(6) | |||||||
Series A Convertible Preferred Stock(7) | $2.5 | 07/09/2007(12) | C | 226,398 | 07/08/2004 | (8) | Common Stock | 2,263,980 | (10) | 0 | D | ||||
Series A Convertible Preferred Stock(7) | $2.5 | 07/09/2007(12) | C | 55,985 | 07/08/2004 | (8) | Common Stock | 559,850 | (10) | 0 | I | See Footnote(1) | |||
Series A Convertible Preferred Stock(7) | $2.5 | 07/09/2007(12) | C | 28,416 | 07/08/2004 | (8) | Common Stock | 284,160 | (10) | 0 | I | See Footnote(2) | |||
Series A Convertible Preferred Stock(7) | $2.5 | 07/09/2007(12) | C | 7,632 | 07/08/2004 | (8) | Common Stock | 76,320 | (10) | 0 | I | See Footnote(3) | |||
Series A Convertible Preferred Stock(7) | $2.5 | 07/09/2007(12) | C | 3,166 | 07/08/2004 | (8) | Common Stock | 31,660 | (10) | 0 | I | See Footnote(4) | |||
Series A Convertible Preferred Stock(7) | $2.5 | 07/09/2007(12) | C | 21,039 | 07/08/2004 | (8) | Common Stock | 210,390 | (10) | 0 | I | See Footnote(5) | |||
Series A Convertible Preferred Stock(7) | $2.5 | 07/09/2007(12) | C | 105,864 | 07/08/2004 | (8) | Common Stock | 1,058,640 | (10) | 0 | I | See Footnote(6) | |||
Stock Options (Right to Purchase) | $7.26 | 05/16/2005 | 05/16/2014 | Common Stock | 10,000 | 10,000 | I | See Footnote(9) | |||||||
Stock Options (Right to Purchase) | $5.11 | 05/12/2006 | 05/12/2015 | Common Stock | 10,000 | 10,000 | I | See Footnote(9) | |||||||
Stock Options (Right to Purchase) | $10.2 | 05/24/2008 | 05/25/2017 | Common Stock | 10,000 | 10,000 | I | See Footnote(9) |
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
|
Explanation of Responses: |
1. The amount shown represents the beneficial ownership of the Issuer's equity securities by J.P. Morgan Partners Global Investors, L.P. The Reporting Person has no pecuniary interest in such securities. |
2. The amount shown represents the beneficial ownership of the Issuer's equity securities by J.P. Morgan Partners Global Investors (Cayman), L.P. The Reporting Person has no pecuniary interest in such securities. |
3. The amount shown represents the beneficial ownership of the Issuer's equity securities by J.P. Morgan Partners Global Investors A, L.P. The Reporting Person has no pecuniary interest in such securities. |
4. The amount shown represents the beneficial ownership of the Issuer's equity securities by J.P. Morgan Partners Global Investors (Cayman) II, L.P. The Reporting Person has no pecuniary interest in such securities. |
5. The amount shown represents the beneficial ownership of the Issuer's equity securities by J.P. Morgan Partners Global Investors (Selldown), L.P. The Reporting Person has no pecuniary interest in such securities. |
6. The amount shown represents the beneficial ownership of the Issuer's equity securities by J.P. Morgan Partners Global Investors (Selldown II), L.P. The Reporting Person has no pecuniary interest in such securities. |
7. The conversion price of the Series A Convertible Preferred Stock is equal to the initial purchase price divided by $2.50, as adjusted for stock splits, stock dividends, combinations and other similar capitalizations of the Issuer's Common and Preferred Stock. Initially this results in a 1 for 10 conversion ratio. Each share of Series A Convertible Preferred Stock is entitled to 0.93 votes for each share of Common Stock into which such share of Convertible Preferred Stock could then be converted. |
8. All outstanding shares of the Issuer's Series A Convertible Preferred Stock are convertible at the holder's option into shares of the Issuer's Common Stock on a 10 to 1 basis any time after July 8, 2004. This right to convert does not expire. |
9. These options were granted to Srinivas Akkaraju, a director of the Issuer. Mr. Akkaraju is obligated to transfer any shares issued under the Stock Option to J.P. Morgan Partners (BHCA), L.P. ("JPM BHCA") at the request of JPM BHCA. |
10. N/A. |
11. This filing is being amended to correct the amount of securities beneficially owned in Table I, Row 4, Box 5 which were previously reported as 79,320. The correct amount is 76,320. |
12. This filing is being amended to correct the dates in Table II, Rows 8-14, Box 3. The dates listed on the filing previously submitted on 7/11/2007 were 2/9/2007. The correct dates are 7/9/2007. |
Remarks: |
This filing is being amended to correct the name of the issuer in Box 2, listed on the issuer's filing on 7/11/2007 as J.P. Morgan Partners Global, L.P. The issuer's correct name is "Seattle Genetics, Inc." |
/s/ J.P. Morgan Partners (BHCA), L.P., By: JPMP Master Fund Manager, L.P., its general partner, By: JPMP Capital Corp., its general partner, By: John C. Wilmot | 07/12/2007 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |